These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16205018)
1. [Pharmaceutical development and clinical experiment of new antidiabetic drugs, premixed preparations of insulin lispro (Humalog Mix 25 and Humalog Mix 50) and intermediate-acting insulin lispro (Humalog N)]. Awa T; Nakata T; Shigeta H Nihon Yakurigaku Zasshi; 2005 Aug; 126(2):143-51. PubMed ID: 16205018 [No Abstract] [Full Text] [Related]
2. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study. Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500 [TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study. Nishimura R; Tsujino D; Taki K; Morimoto A; Tajima N Cardiovasc Diabetol; 2010 May; 9():16. PubMed ID: 20438630 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Hui E; Bravis V; Salih S; Hassanein M; Devendra D Int J Clin Pract; 2010 Jul; 64(8):1095-9. PubMed ID: 20337752 [TBL] [Abstract][Full Text] [Related]
5. Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes. Liu BL; Liu XM; Ren YF; Sun YX; Luo MH; Ye L; Ma JH; Li FF J Diabetes Res; 2020; 2020():8152640. PubMed ID: 32090123 [TBL] [Abstract][Full Text] [Related]
6. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients. Rave K; Heinemann L; Puhl L; Gudat U; Woodworth JR; Weyer C; Heise T Diabetes Care; 1999 May; 22(5):865-6. PubMed ID: 10332707 [No Abstract] [Full Text] [Related]
7. The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approach. Dranitsaris G; Longo CJ; Grossman LD Pharmacoeconomics; 2000 Sep; 18(3):275-87. PubMed ID: 11147394 [TBL] [Abstract][Full Text] [Related]
8. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus. Chapman TM; Noble S; Goa KL Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068 [TBL] [Abstract][Full Text] [Related]
10. Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits. Coscelli C; Iacobellis G; Calderini C; Carleo R; Gobbo M; Di Mario U; Leonetti F; Galluzzo A; Pirrone V; Lunetta M; Casale P; Paleari F; Falcelli C; Valle D; Camporeale A; Merante D Acta Diabetol; 2003 Dec; 40(4):187-92. PubMed ID: 14740279 [TBL] [Abstract][Full Text] [Related]
11. Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical use. Nobels FR; Hermans MP; De Leeuw I Acta Clin Belg; 1999 Oct; 54(5):246-54. PubMed ID: 10555382 [No Abstract] [Full Text] [Related]
12. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group. Roach P; Yue L; Arora V Diabetes Care; 1999 Aug; 22(8):1258-61. PubMed ID: 10480767 [TBL] [Abstract][Full Text] [Related]
13. Insulin lispro: a review of its use in the management of diabetes mellitus. Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA Drugs; 2007; 67(3):407-34. PubMed ID: 17335298 [TBL] [Abstract][Full Text] [Related]
15. Insulin lispro for the treatment of type 2 diabetes. Fisher M Hosp Med; 1999 Nov; 60(11):802-6. PubMed ID: 10707190 [TBL] [Abstract][Full Text] [Related]
16. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes. Hermansen K; Colombo M; Storgaard H; ØStergaard A; Kølendorf K; Madsbad S Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685 [TBL] [Abstract][Full Text] [Related]
17. Premixed insulin analogues for the treatment of diabetes mellitus. Garber AJ Drugs; 2006; 66(1):31-49. PubMed ID: 16398567 [TBL] [Abstract][Full Text] [Related]
18. Premixed insulin treatment for type 2 diabetes: analogue or human? Garber AJ; Ligthelm R; Christiansen JS; Liebl A Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056 [TBL] [Abstract][Full Text] [Related]
19. Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes. Garber AJ Clin Ther; 2005; 27 Suppl B():S39-41. PubMed ID: 16519036 [No Abstract] [Full Text] [Related]
20. Insulin lispro (Humalog), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: overview of pharmacological and clinical data. Hermans MP; Nobels FR; De Leeuw I Acta Clin Belg; 1999 Oct; 54(5):233-40. PubMed ID: 10555380 [No Abstract] [Full Text] [Related] [Next] [New Search]